CD34(+) acute myeloid leukemia cells with low levels of reactive oxygen species show increased expression of stemness genes and can be targeted by the BCL2 inhibitor venetoclax

समान संसाधन

• CITED2 affects leukemic cell survival by interfering with p53 activation
  द्वारा: Mattes, Katharina, और अन्य
  प्रकाशित: (2017)
• RUNX1 mutations enhance self-renewal and block granulocytic differentiation in human in vitro models and primary AMLs
  द्वारा: Gerritsen, Mylène, और अन्य
  प्रकाशित: (2019)
• Elevated VMP1 expression in acute myeloid leukemia amplifies autophagy and is protective against venetoclax-induced apoptosis
  द्वारा: Folkerts, Hendrik, और अन्य
  प्रकाशित: (2019)
• Venetoclax resistance and acquired BCL2 mutations in chronic lymphocytic leukemia
  द्वारा: Tausch, Eugen, और अन्य
  प्रकाशित: (2019)
• Venetoclax Shows Strong Activity in CLL
  द्वारा: Starr, Phoebe
  प्रकाशित: (2016)